Israel Discount Bank of New York’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Israel Discount Bank of New York’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-350	Closed	-$19K	–	419
2017 Q4	$19K	Hold	350	–	–	0.01%	373
2017 Q3	$20K	Hold	350	–	–	0.02%	371
2017 Q2	$21K	Buy	+350	New	+$19.9K	0.02%	367

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Israel Discount Bank of New York's BIVV Position: Q1 2018 in Review

Israel Discount Bank of New York sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 350 shares — an estimated $19K sold.

Israel Discount Bank of New York first reported a position in BIVV in Q2 2017 and held it in 3 quarters. The position peaked at $21K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Israel Discount Bank of New York reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Israel Discount Bank of New York sold 350 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $19K.
Israel Discount Bank of New York first reported a position in Bioverativ Inc. Common Stock in Q2 2017 and held it in 3 quarters.
Israel Discount Bank of New York's Bioverativ Inc. Common Stock position peaked at $21K in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Israel Discount Bank of New York's 13F filing for Q1 2018, filed 17 May 2018.